Kuang-Tai Kuo

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer cell biologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 29, 2025
Correction: Bamodu et al. 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression. Cancers 2018, 10, 269.

Oluwaseun Adebayo Bamodu, Ching-Kuo Yang, Wei-Hong Cheng

|Jul 29, 2022
Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.

Chia-Hung Hsu, Hon-Ping Ma, Jiann Ruey Ong

|Jan 31, 2022
Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm.

Yen-Kuang Lin, Chi-Tai Yeh, Kuang-Tai Kuo

|Nov 13, 2021
PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.

Shin Pai, Vijesh Kumar Yadav, Kuang-Tai Kuo

|Aug 27, 2021
Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression.

Yen-Kuang Lin, Chi-Tai Yeh, Kuang-Tai Kuo

|Jul 28, 2021
Bruton's tyrosine kinase (BTK) mediates resistance to EGFR inhibition in non-small-cell lung carcinoma.

Chi-Tai Yeh, Tzu-Tao Chen, Pamungkas Bagus Satriyo

Pageof 1

Frequent Collaborators

5 joint publications

Chi-Tai Yeh

4 joint publications

Vijesh Kumar Yadav

3 joint publications

Michael Hsiao

2 joint publications

Yen-Kuang Lin